Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

THYP21Shares Hyperliquid Staking ETF

Nasdaq · CIK 0002090011
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end0630
XBRL facts47

Identity from submissions API

Name21Shares Hyperliquid Staking ETF
CIK0002090011
TickersTHYP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6221 Commodity Contracts Brokers & Dealers
EIN000000000
LEI—
Fiscal year end0630
State of incorporationDE DE
Phone646-370-6016
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • 21Shares Hyperliquid ETF (2025-10-29T04:00:00.000Z → 2026-06-25T04:00:00.000Z)
Business address
477 MADISON AVENUE
6TH FLOOR
NEW YORK
NY
10022
NY
Mailing address
477 MADISON AVENUE
6TH FLOOR
NEW YORK
NY
10022
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

17 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-119948 333-291131 261554521 33 234298
2026-11-13 10-Q QUARTERLY REPORT 0001213900-26-119897 001-43278 261554099 34 2511930 1 1
2026-09-25 424I FORM 424I 0001213900-26-103576 333-291131 261411077 33 143740 1 1
2026-09-24 424B3 424B3 0001213900-26-102743 333-291131 261401952 33 839097
2026-09-23 10-K ANNUAL REPORT 0001213900-26-102705 001-43278 261401704 34 3449120 1 1
2026-08-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-094028 333-291131 261323880 33 23649
2026-08-26 8-K CURRENT REPORT 5.03,9.01 0001213900-26-093988 001-43278 261323300 34 585023 1 1
2026-06-25 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-071614 333-291131 261117020 33 203338
2026-06-24 10-Q QUARTERLY REPORT 0001213900-26-071556 001-43278 261116720 34 1730951 1 1
2026-05-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001567 333-291131 26965519 33 1824
2026-05-11 CERT THYP_8A_Cert_2090011.pdf 0001354457-26-000437 001-43278 26964607 34 179769
2026-05-11 424B3 PROSPECTUS 0001213900-26-054478 333-291131 26963256 33 1191056
2026-05-08 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-26-053685 001-43278 26956998 34 16766
2026-04-28 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-26-048260 333-291131 26903169 33 1256106
2026-04-14 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-26-043631 333-291131 26861800 33 3473495
2026-02-13 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-26-016539 333-291131 26634144 33 1151654
2025-10-29 S-1 REGISTRATION STATEMENT 0001213900-25-103237 333-291131 251426667 33 1319292 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (47 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 1.12M 2026-11-09 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
dei EntityPublicFloat Entity Public Float USD 0 2025-12-31 2026 FY 10-K 2026-09-23 0001213900-26-102705
ffd FeeIntrstAmt FeeIntrstAmt USD 0 2026-09-25 424I 2026-09-25 0001213900-26-103576
ffd NetFeeAmt NetFeeAmt USD 7,974.14 2026-09-25 424I 2026-09-25 0001213900-26-103576
ffd TtlFeeAmt TtlFeeAmt USD 7,974.14 2026-09-25 424I 2026-09-25 0001213900-26-103576
ffd TtlFeeAndIntrstAmt TtlFeeAndIntrstAmt USD 7,974.14 2026-09-25 424I 2026-09-25 0001213900-26-103576
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2,004 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 55.60M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap Assets Assets USD 91.12M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap AssetsNet Net Assets USD 90.78M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap Cash Cash USD 338,707 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap CashAvailableForDistributions Cash Available for Distributions USD 338,707 2026-09-29 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.77M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap CryptoAssetPurchase CryptoAssetPurchase USD 2.25M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap CryptoAssetSale CryptoAssetSale USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 338,707 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 21.87M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyDistributionToShareholdersPerShare Investment Company, Distribution to Shareholders, Per Share USD/shares 0.191 2026-09-29 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyExpenseRatioExcludingIncentiveFee Investment Company, Expense Ratio Excluding Incentive Fee pure 0.006 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyIncreaseDecreaseFromShareTransaction InvestmentCompanyIncreaseDecreaseFromShareTransaction USD -2.14M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure 0.012 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease Investment Company, Net Asset Value Per Share, Period Increase (Decrease) USD/shares 13.62 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure 0.006 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentCompanyTotalReturnMarketValue InvestmentCompanyTotalReturnMarketValue pure 0.36 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentIncomeNet Investment Income, Net USD 333,391 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 60.00M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 90.78M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap InvestmentOwnedBalanceContracts Investment Owned, Balance, Contracts pure 1.02M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap Liabilities Liabilities USD 340,711 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 51.29 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap NetInvestmentIncome Net Investment Income USD 217,965 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap OperatingExpenses Operating Expenses USD 115,426 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 22.09M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap RealizedGainLossSecuritySoldShortOperating RealizedGainLossSecuritySoldShortOperating USD 15,613 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 113,007 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap ReceivableInvestmentSale ReceivableInvestmentSale USD 3.01M 2026-06-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 35.18M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 2 2026-03-18 2026-06-30 2026 FY 10-K 2026-09-23 0001213900-26-102705
us-gaap SponsorFees Sponsor Fees USD 50,179 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 90.78M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 280,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares -110,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 13.33M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 390,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 15.48M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 18.14M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001213900-26-119897

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →